Patents Assigned to SCICLONE PHARMACEUTICALS INTERNATIONAL (SG) PTE. LTD.
  • Thymosin alpha 1 for use in treatment of cystic fibrosis
    Patent number: 12083165
    Abstract: The present invention concerns Thymosin alpha 1 (T?1) for use in treatment of cystic fibrosis as a CFTR corrector, CFTR potentiator and anti-inflammatory agent.
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: September 10, 2024
    Assignee: SCICLONE PHARMACEUTICALS INTERNATIONAL (SG) PTE. LTD.
    Inventors: Luigina Romani, Enrico Garaci